Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C N Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114213370B reveals visible light-induced decarboxylation coupling. This method offers mild conditions and high yields for pharmaceutical intermediate manufacturing supply chains.
Novel Pd/Cu catalyzed route offers high yields and simplified purification for complex pharmaceutical intermediates, ensuring supply chain stability.
Patent CN106699600B reveals Fe-catalyzed decarboxylation. Safe, green, cost-effective route for pharmaceutical intermediates.
This patent details a metal-free synthesis method for benzenesulfonamides using iodine catalysts. It offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Patent CN102491862A introduces a green aqueous Suzuki coupling method for biaryl compounds, offering significant cost reduction and simplified supply chain for pharmaceutical intermediates.
Patent CN110183379A reveals a one-pot copper catalyzed route for C-4 sulfone isoquinolinones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111978237B reveals a copper-catalyzed four-component route for high-purity maleimide derivatives, offering significant cost and supply chain advantages.
Patent CN102382058A details a cost-effective Cu(II) catalyzed C-N coupling method for producing high-purity pharmaceutical intermediates with superior stability.
Patent CN101792427A details a mild, high-yield route to polysubstituted furans using Au/Pd catalysis, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN106366054B details non-metal catalytic coupling for ketone synthesis. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Advanced 6-step preparation method for CDK4/6 inhibitor SHR6390. Delivers high purity, mild conditions, and cost reduction in API manufacturing for global supply chains.
Patent CN112979529B reveals a novel one-step synthesis for aromatic amine indole naphthoquinone derivatives, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN112778272B reveals a novel Ir-catalyzed route for 2,2'-biazaaryl ligands, offering significant cost reduction and scalable manufacturing for pharma intermediates.
Patent CN113636968B introduces a ruthenium-catalyzed route for synthesizing pharmaceutical intermediates with exceptional atom economy and simplified manufacturing processes.
Novel ruthenium-catalyzed method enables high-purity 3-acylpyrrole production with enhanced supply chain reliability and significant cost reduction potential for pharmaceutical intermediates.
Breakthrough palladium-catalyzed dehydrogenation coupling method enables high-yield enamide production with mild conditions, enhancing supply chain reliability for pharmaceutical intermediates.
Breakthrough aqueous-phase C-N coupling technology enabling cost-effective production of complex pharmaceutical intermediates with enhanced supply chain reliability.
This patent introduces a water-based iodine-mediated synthesis eliminating organic solvents and enabling scalable production of high-purity indoloquinoline compounds with significant cost reduction potential.
This patent introduces a novel ruthenium-catalyzed alcohol-hydrogen transfer coupling method for synthesizing structurally diverse 3-acylpyrrole compounds with exceptional atom economy and simplified purification protocols enabling reliable supply chain solutions.
Patent CN110878099B enables sustainable production of bioactive alkaloids through iron-catalyzed coupling with enhanced supply chain reliability and cost efficiency.